Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies - PubMed (original) (raw)

Review

Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies

Julien Lanoue et al. J Clin Aesthet Dermatol. 2016 May.

Abstract

Basal cell carcinoma is the most commonly occurring cancer in the world and overall incidence is still on the rise. While typically a slow-growing tumor for which metastases is rare, basal cell carcinoma can be locally destructive and disfiguring. Given the vast prevalence of this disease, there is a significant overall burden on patient well-being and quality of life. The current mainstay of basal cell carcinoma treatment involves surgical modalities, such as electrodessication and curettage, excision, cryosurgery, and Mohs micrographic surgery. Such methods are typically reserved for localized basal cell carcinoma and offer high five-year cure rates, but come with the risk of functional impairment, disfigurement, and scarring. Here, the authors review the evidence and indications for nonsurgical treatment modalities in cases where surgery is impractical, contraindicated, or simply not desired by the patient.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

A) Before: Patient with basal cell carcinoma and local lymph node involvement status post surgical excision, Mohs surgery, and radiation therapy. B) Patient status post two 3-month cycles of vismodegib 150mg daily with a 1-month break in between

Figure 1.

Figure 1.

A) Before: Patient with basal cell carcinoma and local lymph node involvement status post surgical excision, Mohs surgery, and radiation therapy. B) Patient status post two 3-month cycles of vismodegib 150mg daily with a 1-month break in between

Similar articles

Cited by

References

    1. Bulliard JL, Panizzon RG, Levi F. Epidemiology of epithelial skin cancers. Rev Med Suisse. 2009;5(200):882–884-8. - PubMed
    1. Koh D, Wang H, Lee J, et al. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry. Br J Dermatol. 2003;148:1161–1166. - PubMed
    1. Mohan S, Chang AL. Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations. Curr Derm Rep. 2014;3:40–45. - PMC - PubMed
    1. Scotto J, Fears TR, Fraumeni JF, Jr, et al. Incidence of nonmelanoma skin cancer in the United States in collaboration with Fred Hutchinson Cancer Research Center. NIH publication No. 83-2433, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, MD 1983:xv. p.113.
    1. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, Arch Dermatol. 2010;146(3):283–287. - PubMed

Publication types

LinkOut - more resources